This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAJ Douglas S. Walsh, MC; CPT Cary L. Dunn, MC; COL William D. James, MC

Arch Dermatol. 1995;131(12):1373-1375.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF A CASE

A 32-year-old healthy white man with androgenetic alopecia (AGA)(Hamilton-Norwood stage V) of 10 years' duration presented for therapy (Figure 1). The patient desired to pursue medical treatment only.

THERAPEUTIC CHALLENGE

To optimize the opportunity for hair regrowth in a patient with advanced, extensive AGA using nonsurgical intervention.

SOLUTION

Following informed consent, the patient agreed to a 6to f 2-month trial of topical minoxidil in an optimized retinoid vehicle applied twice per day and 5 mg of finasteride taken orally each day. The topical solution was prepared as follows: minoxidil tablets were dissolved in distilled water, polyethylene glycol, and absolute ethanol (volume ratio, 20:30:50, respectively) to a final minoxidil concentration of 3.75% (grams per deciliter). Following filtration, the 3.75% minoxidil solution was combined with 0.05% tretinoin (4:1 vol/vol) for final concentrations of 3% minoxidil and 0.01% tretinoin. The preparation was stored at room temperature and protected from . . . [Full Text PDF of this Article]

Author Affiliations
USA; USA; USA; Walter Reed Army Medical Center, Washington, DC

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?